Genexine Inc., established more than 20 years ago, has now reached a juncture where it needs significant changes in strategy to move forward towards its ambition of become a leading global biopharma operation over the next several years.
With this in mind, the South Korean biotech appointed global pharma veteran Neil Warma as its new president and CEO last year, with a focus on advancing key products to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?